| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 05/10/2006 | EP1654218A2 Matrix metalloproteinase inhibitors |
| 05/10/2006 | EP1653945A2 Glycosidase inhibitors and methods of synthesizing same |
| 05/10/2006 | CN1771323A L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols |
| 05/10/2006 | CN1771247A Oxime derivatives and their use as pharmaceutically active agents. |
| 05/10/2006 | CN1771243A Sulfamate benzothiophene ester derivatives as steroid sulfatase inhibitors |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769281A Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents |
| 05/10/2006 | CN1768932A Expanded graphite supporting NiB amorphous alloy catalyst, its preparation method and application |
| 05/10/2006 | CN1255413C (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
| 05/10/2006 | CN1255396C Carboxylic acid derivatives having fused rings |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/04/2006 | WO2006047302A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/04/2006 | WO2006046916A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2006046508A1 Ruthenium complex and process for producing tert-alkyl alcohol therewith |
| 05/04/2006 | WO2006045255A1 Method of manufacturing (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) |
| 05/04/2006 | WO2006029210A3 Acyclic 1,3-diamines and uses therefor |
| 05/04/2006 | WO2006004903A3 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof |
| 05/04/2006 | US20060094899 Process for preparing ruthenium-carrying alumina and process for oxidizing alcohol |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094768 Thiophene derivative ppar modulators |
| 05/04/2006 | US20060094764 Cyanothiophenes, their preparation and their use in pharmaceutical compositions |
| 05/04/2006 | US20060094747 Substituted carboxylic acids |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060094694 Heterocyclic compounds and thrombopoietin receptor activators |
| 05/04/2006 | CA2584465A1 Heterocyclic carbonyl compounds and their use as sgk-inhibitors |
| 05/04/2006 | CA2584413A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584409A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2580690A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/03/2006 | EP1651629A1 Substituted benzothiophene compounds and uses thereof |
| 05/03/2006 | EP1651602A2 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1543011B1 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 05/03/2006 | EP1363618B1 Pharmaceutical composition for treating multiple sclerosis |
| 05/03/2006 | EP1280791B1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | CN1768031A Novel hydroxamates as therapeutic agents |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/03/2006 | CN1765893A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/03/2006 | CN1254472C Chemical synthesis method for acyl thiophene |
| 05/03/2006 | CN1254465C Calcilytic compounds |
| 05/02/2006 | US7038084 Viricides; Aids therapy |
| 05/02/2006 | US7038070 Coordination polymerization catalysts |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 05/02/2006 | US7037938 For therapy of urinary incontinence |
| 05/02/2006 | US7037937 Cytotoxic compounds |
| 05/02/2006 | US7037932 such as (lepido%3S)-3-(1-Benzothien-7-yloxy)-N-methyl-3-phenyl-1-propanamine oxalate; for treatment of pain |
| 05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 04/27/2006 | WO2006044826A2 Thiophens and their use as anti-tumor agents |
| 04/27/2006 | WO2006042850A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 04/27/2006 | WO2006042481A1 Method of obtaining clopidogrel |
| 04/27/2006 | WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | US20060089403 thiophene-2,5-dicarboxylic acid 2-[(2-amino-phenyl)-amide]5-octylamide; histone deacetylase inhibitors; anticancer agents; low toxicity; potent antiproliferative and cell differentiation activity; two-step one-pot procedure; activation of carboxylated derivative in inert solvents then amination |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | DE102004051188A1 Cyanothiophene, deren Herstellung und deren Verwendung als Arzneimittel Cyanothiophenes, their preparation and their use as medicaments |
| 04/27/2006 | CA2584918A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 04/26/2006 | EP1650202A1 4,5-DIHYDRONAPHTHO [1,2-b] THIOPHENE DERIVATIVE |
| 04/26/2006 | CN1764657A Trifluoromethyl-thiophene carboxylic acid anilides and use thereof as fungicides. |
| 04/26/2006 | CN1763060A Metallocene compound, indene compound and application thereof |
| 04/26/2006 | CN1763035A Oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 04/26/2006 | CN1762989A Semicarbazone synthesis method |
| 04/26/2006 | CN1762957A 2,3-dihydro-1-indene compound and preparation method thereof |
| 04/26/2006 | CN1253448C Preparation of thiophene monomer and its polymerizing method |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034053 beta-adrenoceptor agonist for the prevention or treatment of obesity; Suitable compounds of formula (I) of the invention include:2-(3-{2R-[2-(3-Chlorophenyl)-2R-hydroxyl-ethylamino]propylamino}phenyl)furan-3-carboxylic acid |
| 04/25/2006 | US7034045 Monofluoroalkyl derivatives |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7033727 Photosensitive composition and acid generator |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006040177A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor |
| 04/20/2006 | WO2006040136A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder |
| 04/20/2006 | WO2006040131A1 Iron or cobalt-catalyzed carbon-carbon coupling reaction of aryls, alkenes and alkines with copper reagents |
| 04/20/2006 | WO2006020156A3 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease |
| 04/20/2006 | WO2006019497A3 Sleep-inducing compounds and methods related thereto |
| 04/20/2006 | WO2005096734A3 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084696 FIBROSIS; ALZHEIMER'S DISEASE, Parkinson's disease, autoimmune disease, wound healing, osteoporosis; ANTIARTHRITIC AGENTS, anticholesterol agents |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | CA2583967A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583015A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1646616A2 Combretastatin derivatives with cytotoxic action |
| 04/19/2006 | EP1646608A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 04/19/2006 | EP1383736A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761646A Cannabinoid receptor ligands |
| 04/19/2006 | CN1761464A Substituted p-diaminobenzene derivatives |